ATE364079T1 - Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung - Google Patents

Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung

Info

Publication number
ATE364079T1
ATE364079T1 AT93911529T AT93911529T ATE364079T1 AT E364079 T1 ATE364079 T1 AT E364079T1 AT 93911529 T AT93911529 T AT 93911529T AT 93911529 T AT93911529 T AT 93911529T AT E364079 T1 ATE364079 T1 AT E364079T1
Authority
AT
Austria
Prior art keywords
peptides
nucleic acid
acid sequences
sequences coding
production
Prior art date
Application number
AT93911529T
Other languages
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE364079T1 publication Critical patent/ATE364079T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93911529T 1992-04-21 1993-04-19 Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung ATE364079T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9204827A FR2690162B1 (fr) 1992-04-21 1992-04-21 Peptides ayant une activite de facteur d'echange du gdp, sequences d'acides nucleiques codant pour ces peptides, preparation et utilisation.

Publications (1)

Publication Number Publication Date
ATE364079T1 true ATE364079T1 (de) 2007-06-15

Family

ID=9429043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911529T ATE364079T1 (de) 1992-04-21 1993-04-19 Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung

Country Status (11)

Country Link
US (1) US5656595A (de)
EP (1) EP0637334B1 (de)
JP (1) JP3681384B2 (de)
AT (1) ATE364079T1 (de)
CA (1) CA2131166A1 (de)
DE (1) DE69334146T2 (de)
DK (1) DK0637334T3 (de)
ES (1) ES2287927T3 (de)
FR (1) FR2690162B1 (de)
PT (1) PT637334E (de)
WO (1) WO1993021314A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840683A (en) * 1995-09-21 1998-11-24 Innapharma, Inc. Peptides inhibiting the oncogenic action of p21 ras
US5910478A (en) * 1995-09-21 1999-06-08 Innapharma, Inc. Peptidomimetics inhibiting the oncogenic action of p21 ras
US6340575B1 (en) * 1997-06-17 2002-01-22 Onyx Pharmaceuticals, Inc. Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
IT1293491B1 (it) * 1997-07-08 1999-03-01 Dompe Spa Mutanti di proteine gef e plasmidi idonei per la loro sintesi
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US6699672B1 (en) 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
IT1306190B1 (it) * 1999-01-04 2001-05-30 Dipartimento Di Biotecnologie Mutanti di proteine e plasmidi idonei per la loro sintesi.
EP1157118A4 (de) * 1999-03-01 2002-07-17 Insight Strategy & Marketing POLYNUKLEOTID, DAS FüR EIN POLYPEPTID MIT HEPARANASE-AKTIVäT KODIERT, UND DESSEN EXPRESSION IN GENETISCH VERäNDERTEN ZELLEN
EP1278848A1 (de) * 2000-05-05 2003-01-29 MERCK PATENT GmbH Neuer ras-guanin-nukleotid-austauschfaktor-1 (nrg1)
FR2812945B1 (fr) * 2000-08-10 2002-10-04 Aventis Pharma Sa Utilisation de la proteine grf1 et cellules exprimant la proteine grf1 pour le criblage de molecules
US7122345B2 (en) 2001-01-09 2006-10-17 Curagen Corporation Nucleic acid encoding a NOVX13 polypeptide
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
WO2004003152A2 (en) * 2002-06-26 2004-01-08 Chiron Corporation Sos1 inhibitors
WO2004064479A2 (en) * 2003-01-17 2004-08-05 Children's Medical Center Corporation Neuroprotective therapeutics and assays for identifying the same
US20060269552A1 (en) * 2003-06-09 2006-11-30 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2065017A1 (en) * 1989-08-21 1991-02-22 Cetus Oncology Corporation Peptides from gtpase-activating protein (gap) and diagnostic and therapeutic use thereof

Also Published As

Publication number Publication date
DE69334146T2 (de) 2008-01-31
EP0637334A1 (de) 1995-02-08
FR2690162B1 (fr) 1995-08-04
JP3681384B2 (ja) 2005-08-10
DE69334146D1 (de) 2007-07-19
PT637334E (pt) 2007-09-07
FR2690162A1 (fr) 1993-10-22
CA2131166A1 (fr) 1993-10-28
DK0637334T3 (da) 2007-10-08
WO1993021314A1 (fr) 1993-10-28
EP0637334B1 (de) 2007-06-06
JPH07505774A (ja) 1995-06-29
ES2287927T3 (es) 2007-12-16
US5656595A (en) 1997-08-12

Similar Documents

Publication Publication Date Title
ATE364079T1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
DE69326250D1 (de) Neuropeptide y antagoniste
ATE202785T1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DE69228749D1 (de) Neuartige polypeptide und ihre verwendung
ATE155485T1 (de) Bpc-peptide, ihre herstellung und verwendung
DE69900756D1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
ATE345139T1 (de) Karzinostatische wirkstoffe
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
DE69530404D1 (de) Analogen des keratinozytenwachstumfaktors
HUT77029A (hu) A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk
ATE242202T1 (de) Peptide
AU669149B2 (en) Expression signal-peptide-free staphylokinases
DE58906606D1 (de) Optisch aktive Rhodiumkomplexe von 3,4-Bis(diarylphosphino)-pyrrolidinen und ihre Verwendung zur Herstellung von Phosphinothricin durch asymmetrische Hydrierung.
ATE213742T1 (de) Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
ATE309359T1 (de) Epil/plazentin
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ES2097931T3 (es) Nueva proteina inhibidora de trombina a partir de chinches cazadoras.
ATE94168T1 (de) Peptide.
DE69812597D1 (de) Peptide zur Inhibition von HPV E7 Proteinen
AU4405689A (en) New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0637334

Country of ref document: EP

REN Ceased due to non-payment of the annual fee